Text messaging for improving antiretroviral therapy adherence: No effects after 1 year in a randomized controlled trial among adolescents and young adults

American Journal of Public Health

Volumn 107, Issue 12, 2017, Pages 1944-1950

  Linnemayr, Sebastian ^a   Huang, Haijing ^a   Luoto, Jill ^a   Kambugu, Andrew ^b   Thirumurthy, Harsha ^c   Haberer, Jessica E ^d   Wagner, Glenn ^a   Mukasa, Barbara ^e  

^a RAND CORPORATION   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c IL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MILDMAY UGANDA   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY; BEHAVIOR CHANGE; CASE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TEXT MESSAGING; TRANSCRIPTION INITIATION; UGANDA; YOUNG ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CLINICAL TRIAL; HIV SEROPOSITIVITY; INTENTION TO TREAT ANALYSIS; MEDICATION COMPLIANCE; REMINDER SYSTEM;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIINFECTIVE AGENT; COTRIMOXAZOLE;

ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; FEMALE; HIV SEROPOSITIVITY; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MEDICATION ADHERENCE; OUTCOME ASSESSMENT (HEALTH CARE); REMINDER SYSTEMS; TEXT MESSAGING; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION; UGANDA; YOUNG ADULT;

EID: 85033578924     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2017.304089     Document Type: Article

References (29)

1. Qiang CZ, Yamamichi M, Hausman V, Altman D. Mobile Applications for the Health Sector. Washington, DC: World Bank; 2011.
2. Li JZ, Paredes R, Ribaudo HJ, et al. Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure. AIDS. 2012;26(2):185–192.
3. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy JV, Montaner JS. The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr. 2004;35(3):261–268.
4. Hogg RS, Heath K, Bangsberg D, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16(7): 1051–1058.
5. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–1183.
6. Shuter J, Sarlo JA, Stubbs RO, Rode RA, Zingman BS. Sequential antiretroviral adherence measurement using electronic bottle cap monitors in a cohort of HIV-infected adults. J Int Assoc Physicians AIDS Care (Chic). 2012;11(2): 94–97.
7. Ortego C, Huedo-Medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–1396.
8. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.
9. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338(13):853–860.
10. Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomized trial. Lancet. 2010;376(9755):1838–1845.
11. Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25(6):825–834.
12. Horvath T, Azman H, Kennedy GE, Rutherford GW. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev. 2012;(3): CD009756.
13. DeKoekkoek T, Given B, Given CW, Ridenour K, Schueller M, Spoelstra SL. mHealth SMS text messaging interventions and to promote medication adherence: an integrative review. J Clin Nurs. 2015;24(19-20):2722–2735.
14. Mbuagbaw L, Thabane L, Ongolo-Zogo P, et al. The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One. 2012;7(12): e46909.
15. Shet A, De Costa A, Kumarasamy N, et al. Effect of mobile telephone reminders on treatment outcome in HIV: evidence from a randomized controlled trial in India. BMJ. 2014;349:g5978.
16. Cramer J, Vachon L, Desforges C, Sussman NM. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical-trial. Epilepsia. 1995;36(11):1111–1117.
17. Steinberg L, Graham S, O'Brien L, Woolard J, Cauffman E, Banich M. Age differences in future orientation and delay discounting [erratum in Child Dev. 2010;81(3):1024]. Child Dev. 2009;80(1):28–44.
18. Mitchell KJ, Bull S, Kiwanuka J, Ybarra ML. Cell phone usage among adolescents in Uganda: acceptability for relaying health information. Health Educ Res. 2011; 26(5):770–781.
19. Ware NC, Pisarski EE, Tam M, et al. The meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016;30(8):1287–1294.
20. Wald DS, Butt S, Bestwick JP. One-way versus two-way text messaging on improving medication adherence: meta-analysis of randomized trials. Am J Med. 2015;128(10):1139.e1–5.
21. Schulz KF, Grimes DA. Unequal group sizes in randomized trials: guarding against guessing. Lancet. 2002; 359(9310):966–970.
22. Thirumurthy H, Siripong N, Vreeman RC, et al. Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting. AIDS. 2012;26(18):2399–2403.
23. Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–245.
24. Rana Y, Haberer J, Huang HJ, et al. Short Message Service (SMS)-based intervention to improve treatment adherence among HIV-positive youth in Uganda: focus group findings. PLoS One. 2015;10(4):e0125187.
25. Perneger TV. Adjusting for multiple testing in studies is less important than other concerns. BMJ. 1999; 318(7193):1288.
26. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298.
27. Wools-Kaloustian K, Kimaiyo S, Diero L, et al. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS. 2006;20(1):41–48.
28. Cell phones in Africa: communication lifeline. Pew Research Center. April 2015.
29. Aker JC, Mbiti IM. Mobile phones and economic development in Africa. J Econ Perspect. 2010;24(3): 207–232.